Closing Bell: Medicenna Therapeutics Corp down on Tuesday (MDNA)
Today during trading, shares of Medicenna Therapeutics Corp opened at $2.07 and closed at $2.04. It traded at a low of $1.99 to a high of $2.07.
The price eased -0.97 percent from the previous day's close of $2.06.
Today across North America, the TSX Composite closed 0.20% at 22824.67, the S&P 500 closed 0.08% at 5463.54, the Dow Jones Industrial Average closed -0.12% at 40539.93 and the Nasdaq Composite closed 0.07% at 17370.20.
Medicenna Therapeutics Corp traded under MDNA on the Toronto Stock Exchange (TSX).
A total of 14,457 shares was traded during the session, with total trades of 48, with an average volume of 79,135 over 5 days.
The TSX overall saw 2,584 price advancers against 2,644 declines and 86 unchanged.
During the prior 52 weeks, MDNA.TO has traded as high as $2.98 (June 03,2024) and low as $0.22 (November 01,2023). Moreover, the shares have risen 257.89% in the last year, while in 2024, they have risen 385.71%.
Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $154.04 million on a float of 74,779 shares outstanding. Its annual EPS is $-0.23.
Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.
Based on 2.00 analysts, Medicenna Therapeutics Corp gets an average recommendation of "Strong Buy" according to Zacks. Currently, there are 2 buy ratings for the stock.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
